Cargando…
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that leads to progressive weakness from loss of motor neurons and death on average in less than 3 years after symptom onset. No clear causes have been found and just one medication, riluzole, extends survival. Researchers have ident...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431958/ https://www.ncbi.nlm.nih.gov/pubmed/22956874 http://dx.doi.org/10.2147/TCRM.S21981 |